Interplay among bacterial resistance, biofilm formation and oxidative stress for nosocomial infections

Free Radicals in Human Health and Disease

Volumn , Issue , 2015, Pages 369-379

  Gabrani, Reema ^a   Sharma, Garima ^a   Dang, Shweta ^a   Gupta, Sanjay ^a  

^a JAYPEE INSTITUTE OF INFORMATION TECHNOLOGY   (India)

Author keywords

Antibiotics; P. aeruginosa; Quorum sensing; Reactive oxygen species; S. epidermidis; Therapeutics

Indexed keywords

EID: 84943311704     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-81-322-2035-0_23     Document Type: Chapter

References (69)

1. Kramer A, Schwebke I, Kampf G (2006) How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 6:130. doi: 10.1186/1471-2334-6-130
2. Inweregbu JD, Pittard A (2005) Nosocomial infections. Continuing education in Anaesthesia. Crit Care & Pain 5:14–17
3. Hsueh P-R, Chen W-H, Luh K-T (2006) Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991–2003 at a university hospital in Taiwan. Int J Antimicrob Agents 26:463–472
4. Robert C, Welliver MD, McLaughlin S (1984) Unique epidemiology of nosocomial infection in a children’s hospital. Am J Dis Child 138(2):131–135
5. Robert A, Weinstein RG et al (2005) Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 41(6):848–854
6. Harold C (1992) The crisis in antibiotic resistance. Science 257:1064–1073
7. Philip S, Stewart J, Costerton JW (2001) Antibiotic resistance of bacteria in biofilms. Lancet 358:135–138
8. Merle E, Olson, Ceri H, Douglas WM (2002) Biofilm bacteria: formation and comparative susceptibility to antibiotics. Can J Vet Res 66(2):86–92
9. Beloin C, Ghigo JM (2005) Finding gene-expression patterns in bacterial biofilms. Trends Microbiol 13(1):16–19
10. Pratt LA, Roberto K (1999) Genetic analyses of bacterial biofilm formation. Curr Opin Microbiol 2:598–603
11. Sharma G, Rao S, Bansal A et al (2014) Pseudomonas aeruginosa biofilm: potential therapeutic targets. Biologicals 42:1–7
12. Govan JR, Deretic V (1996) Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkolderia cepacia. Microbiol Rev 60:539–574
13. Musken M, Di Fiore S, Dotsch A et al (2006) Genetic determinants of Pseudomonas aeruginosa biofilm establishment. Microbiology 156:431–441
14. McKnight SL, Iglewski BH, Pesci EC (2000) The Pseudomonas quinolone signal regulates rhl quorum sensing in Pseudomonas aeruginosa. J Bacteriol 182:2702–2708
15. Cao H, Krishnan G, Goumnerov B et al (2000) A quorum sensing-associated virulence gene of Pseudomonas aeruginosa encodes a LysR-like transcription regulator with a unique self-regulatory mechanism. J Sci Proc Natl Acad Sci U S A 98:14613–14618
16. Diggle SP, Cornelis P, Williams P et al (2006) 4-Quinolone signalling in Pseudomonas aeruginosa: old molecules, new perspectives. J Sci Med Microbiol 296:83–91
17. Pearson JP, Gray KM, Passador L et al (1994) Structure of autoinducer required for expression of Pseudomonas aeruginosa virulence genes. Proc Natl Acad Sci U S A 91:197–201
18. Gambello MJ, Kaye S, Iglewski BH (1993) LasR of Pseudomonas aeruginosa is a transcriptional activator of alkaline protease gene (apr) and an enhancer of exotoxin A expression. Infect Immun 61:1180–1184
19. Friedman L, Kolter R (2004) Genes involved in matrix formation in Pseudomonas aeruginosa PA14 biofilm. J Sci Mol Microbiol 51:675–690
20. Prigent-Combaret C, Vidal O, Dorel C et al (1999) Abiotic surface sensing and biofilm-dependent regulation of gene expression in Escherichia coli. J Bacteriol 181(19):5993–6002
21. Li YH, Tang N, Aspiras MB, Lau PC et al (2002) A quorum-sensing signaling system essential for genetic competence in Streptococcus mutans is involved in biofilm formation. J Bacteriol 184:2699–2708
22. González-Hein G, Huaracán B, García P et al (2014) Prevalence of virulence genes in strains of Campylobacter jejuni isolated from human, bovine and broiler. Microbiology 44:1223–1229
23. Cole SJ, Records AR, Orr MW, Linden SB, Lee VT (2014) Catheter-associated urinary tract infection by Pseudomonas aeruginosa is mediated by exopolysaccharide independent biofilms. Infect Immun 82(5):2048–2058
24. Zhou S, Chao X, Fei M, Dai Y, Liu B (2013) Analysis of S. epidermidis icaA and icaD genes by polymerase chain reaction and slime production: a case control study. BMC Infect Dis 13:242
25. Diani M, Esiyok OG, Ariafar MG et al (2014) The interactions between esp, fsr, gelE genes and biofilm formation and pfge analysis of clinical Enterococcus faecium strains. Afr J Microbiol Res 8:129–137
26. Wassinger A, Zhang L, Tracy E et al (2013) Role of a GntR-family response regulator LbrA in Listeria monocytogenes biofilm formation. PLoS One 8:e70448
27. McCann T, Brendan FG, Sean PG (2008) Staphylococcus epidermidis device-related infections: pathogenesis and clinical management. Maureen 60:1551–1571
28. Lucas RH, David AD, Michael JM et al (2005) Aminoglycoside antibiotics induce bacterial biofilm formation. Nature 436:1171–1175
29. Strohl WR (1997) Biotechnology of antibiotics. Marcel Dekker Inc, New York
30. Benton B, Breukink E, Visscher et al (2007) Telavancin inhibits peptidoglycan biosynthesis through preferential targeting of transglycosylation: evidence for a multivalent interaction between telavancin and lipid II. Int J Antimicrob Agents 29:S51–S52
31. Leach KL, Swaney SM, Colca JR et al (2007) The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria. Mol Cell 26:393–402
32. Tenover FC (2006) Mechanisms of antimicrobial resistance in bacteria. Am J Med 119:3–10
33. Straus SK, Hancock RWE (2006) Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides. Biochim Biophys Acta 1758:1215–1223
34. Kotra LP, Mobashery S (1999) Mechanistic and clinical aspects of b-lactam antibiotics and b-lactamases. Arch Immunol Ther Exp (Warsaw) 47:211–216
35. Poole K (2004) Resistance to b-lactam antibiotics. Cell Mol Life Sci 61:2200–2223
36. Bush K, Jacoby GA, Medeiros AA (1995) A functional classification scheme for b-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 39:1211–1233
37. Bonnet R (2004) Growing group of extendedspectrum beta-lactamases, The CTX-M enzymes. Antimicrob Agents Chemother 48:1–14
38. Yazawa K, Mikami Y, Maeda A et al (1994) Phosphorylative inactivation of rifampicin by Nocardia otitidiscaviarum. J Antimicrob Chemother 33:1127–1135
39. Nakamura A, Miyakozawa I, Nakazawa K et al (2000) Detection and characterization of a macrolide 2’-phosphotransferase from Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother 44:3241–3242
40. Matsuoka M, Sasaki T (2004) Inactivation of macrolides by producers and pathogens. Curr Drug Targets Infect Disord 4:217–240
41. Yang W, Moore IF, Koteva KP et al (2004) TetX is a flavin-dependent monooxygenase conferring resistance to tetracycline antibiotics. J Biol Chem 279:52346–52352
42. Nagai K, Davies TA, Jacobs MR et al (2002) Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillinsusceptible, -intermediate, and -resistant pneumococci. Antimicrob Agents Chemother 46:1273–1280
43. Kosowska K, Jacobs MR, Bajaksouzian S et al (2004) Alterations of penicillin-binding proteins 1A, 2X, and 2B in Streptococcus pneumoniae isolates for which amoxicillin MICs are higher than penicillin MICs. Antimicrob Agents Chemother 48:4020–4022
44. Dowson CG, Coffey TJ, Spratt BG (1994) Origin and molecular epidemiology of penicillin-bindingprotein- mediated resistance to b-lactam antibiotic. Trends Microbiol 2:361–366
45. Weisblum B (1998) Macrolide resistance. Drug Resist Updat 1:29–41
46. Spigaglia P, Mastrantonio P (2002) Analysis of macrolide- lincosamide- streptogramin B (MLSB) resistance determinant in strains of Clostridium difficile. Microb Drug Resist 8:45–53
47. Ackermann G, Degner A, Cohen SH et al (2003) Prevalence and association of macrolide-lincosamidestreptogramin B (MLSB) resistance with resistance to moxifloxacin in Clostridium difficile. J Antimicrob Chemother 51:599–603
48. Khodursky AB, Zechiedrich EL, Cozzarelli NR (1995) Topoisomerase IV is a target of quinolones in Escherichia coli. Proc Natl Acad Sci U S A 92:11801–11805
49. Ince D, Zhang X, Silver LC et al (2002) Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone. Antimicrob Agents Chemother 46:3370–3380
50. Nikaido H, Zgurskaya HI (1999) Antibiotic efflux mechanisms. Curr Opin Infect Dis 12:529–536
51. Webber MA, Piddock LJ (2003) The importance of efflux pump in bacterial antibiotic resistance. J Antimicrob Chemother 51:9–11
52. Van Veen HW, Konings WN (1997) Drug efflux proteins in multidrug resistant bacteria. Biol Chem 378:769–777
53. Poole K (2001) Multidrug efflux pumps and antimicrobial resistance in P. aeruginosa and related organisms. J Mol Microbiol Biotechnol 3:225–264
54. Gotoh N, Tsujimoto H, Poole K et al (1995) The outer membrane protein OprM of Pseudomonas aeruginosa is encoded by oprK of the mexA-mexB-oprK multidrug resistance operon. Antimicrob Agents Chemother 39:2567–2569
55. Köhler T, Epp SF, Curty LK et al (1999) Characterization of MexT, the regulator of the MexEMexF- OprN multidrug efflux system of Pseudomonas aeruginosa. J Bacteriol 181:6300–6305
56. Langton KP, Henderson PJF, Herber RB (2005) Antibiotic resistance: multidrug efflux proteins, a common transport mechanism? Nat Prod Rep 22:439–451
57. Putman M, Van HW, Konings WN (2000) Molecular properties of bacterial multidrug transporters. Microbiol Mol Biol Rev 64:672–693
58. Suo Y, Huang Y, Liu Y et al (2012) The expression of superoxide dismutase (SOD) and a putative ABC transporter permease is inversely correlated during biofilm formation in Listeria monocytogenes 4bG. PLoS One. doi: 10.1371/journal.pone.0048467
59. Liu X, Sun X, Wu Y et al (2013) Oxidation-sensing regulator AbfR regulates oxidative stress responses, bacterial aggregation, and biofilm formation in Staphylococcus epidermidis. J Biol Chem 288(6): 3739–3752
60. Lefu L, Thomas S, Barbara IK et al (2010) Pseudomonas aeruginosa OspR is an oxidative stress sensing regulator that affects pigment production, antibiotic resistance and dissemination during infection. Mol Microbiol 75:76–91
61. Boles BB, Pradeep K (2008) Endogenous oxidative stress produces diversity and adaptability in biofilm communities. Proc Natl Acad Sci U S A 105:12503–12508
62. Zeng Z, Qian L, Cao L et al (2008) Virtual screening for novel quorum sensing inhibitors to eradicate biofilm formation of Pseudomonas aeruginosa. Appl Microbiol Biotechnol 79:119e26
63. Jakobsen TH, Van Gennip M, Phipps RK, Alhede M et al (2012) Ajoene, a sulfur-rich molecule from garlic inhibits genes controlled by quorum sensing. Antimicrob Agents Chemother 56: 2314e25
64. Sun D, Accavitti MA, Bryers JD (2005) Inhibition of biofilm formation by monoclonal antibodies against Staphylococcus epidermidis RP62A accumulationassociated protein. Clin Diagn Lab Immunol 12:93–100
65. Digiandomenico A, Warrener P, Hamilton M et al (2012) Identifi cation of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening. J Sci Exp Med 209: 1273e87
66. Eckhart L, Fischer H, Barken KB et al (2007) DNase1L2 suppresses biofilm formation by Pseudomonas aeruginosa and Staphylococcus aureus. J Sci Br J Dermatol 156:1342e5
67. Alemayehu D, Casey PG, McAuliffe O et al (2012) Bacteriophages fMR299-2 and fNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. mBio 3:e00029
68. Biel MA, Sievert C, Usacheva M et al (2011) Reduction of endotracheal tube biofilms using antimicrobial photodynamic therapy. J Sci Lasers Surg Med 4: 586e90
69. Dean SN, Bishop BN, Van Hoek ML (2011) Susceptibility of Pseudomonas aeruginosa biofilm to alpha-helical peptides: D-enantiomer of LL-37. J Sci Front Microbiol 2: 122e8